JP Morgan JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Highlights of the second day included Myriad Genetics' new oncology testing service and more details on SomaLogic's partnership with Illumina. JP Morgan Initiates Coverage of Oxford Nanopore Technologies With Overweight Rating Oxford Nanopore is a "differentiated player, operating in an attractive segment, with a very strong long-term top-line growth outlook," according to a JP Morgan analyst. PerkinElmer Reaches Deal for $1.5B Credit Facility The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility. JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings Both investment banks are bullish on the genomic data analysis firm, which went public on the Nasdaq a month ago, raising $234 million in gross proceeds. PerkinElmer Enters $500M Credit Facility The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month. Jun 21, 2021 JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems May 24, 2021 Singular Genomics Ups IPO Target to $187M May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Feb 18, 2021 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan Dec 3, 2020 Twist Bioscience Prices Upsized $300M Public Offering Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 3, 2020 Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations Premium Oct 14, 2020 JP Morgan Rates Invitae Neutral Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Oct 7, 2020 NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent Oct 2, 2020 Pacific Biosciences Upgraded to Overweight by JP Morgan Sep 21, 2020 Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider Premium Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Sep 11, 2020 10x Genomics Prices Upsized $440M Public Offering Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.